These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3011258)

  • 21. [Effect of dimetpramid and metoclopramide on the rate of catecholamine turnover in the subcortical-stem structures of the rat brain].
    Legeza VI; Kamynina MF; Markovskaia IV; Shagoian MG; Martirosov KS
    Farmakol Toksikol; 1986; 49(4):25-7. PubMed ID: 3019759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related changes in glutamate receptors: an autoradiographic analysis.
    Wardas J; Pietraszek M; Schulze G; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1997; 49(6):401-10. PubMed ID: 9566043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
    Alburges ME; Narang N; Wamsley JK
    Synapse; 1993 Aug; 14(4):314-23. PubMed ID: 8161369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of subtypes of alpha-2 adrenoceptors in the human brain.
    Ordway GA; Jaconetta SM; Halaris AE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):967-76. PubMed ID: 8382286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines: synthesis and adrenergic and dopaminergic activity studies.
    Tagmatarchis N; Thermos K; Katerinopoulos HE
    J Med Chem; 1998 Oct; 41(21):4165-70. PubMed ID: 9767652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P
    Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
    Fuxe K; Agnati LF; Benfenati F; Celani M; Zini I; Zoli M; Mutt V
    J Neural Transm Suppl; 1983; 18():165-79. PubMed ID: 6192208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain neurotransmitter receptor alterations in offspring of rats exposed to phenobarbital, phenytoin or their combination during pregnancy.
    Seth PK; Alleva FR; Takagi S; Yen-Koo HC; Balazs T
    Neurotoxicology; 1987; 8(1):45-53. PubMed ID: 3031564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.
    Hamik A; Peroutka SJ
    Cancer Chemother Pharmacol; 1989; 24(5):307-10. PubMed ID: 2527092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptics and their metabolites binding to alpha 1 and D2 receptors.
    Osman OT; Becker RE
    Biol Psychiatry; 1988 Nov; 24(7):815-8. PubMed ID: 2906546
    [No Abstract]   [Full Text] [Related]  

  • 35. Binding affinity of levomepromazine and two of its major metabolites of central dopamine and alpha-adrenergic receptors in the rat.
    Dahl SG; Hall H
    Psychopharmacology (Berl); 1981; 74(2):101-4. PubMed ID: 6115442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of urethane administration on somatostatin receptors in rat cerebral cortex and pituitary.
    Iwahana H; Komatsu M; Mitsuhashi S; Kubo K; Saito H; Saito S
    Tokushima J Exp Med; 1988 Dec; 35(3-4):69-77. PubMed ID: 2908214
    [No Abstract]   [Full Text] [Related]  

  • 37. Human serum Cohn fraction IV (alpha-globulin [correction of globin] enriched) inhibits ligand binding at neurotransmitter receptors in human brain.
    Andorn AC; Pappolla MA; Fox H; Klemens FK; Martello PA
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4572-5. PubMed ID: 3012573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.
    Hamik A; Peroutka SJ
    Biol Psychiatry; 1989 Mar; 25(5):569-75. PubMed ID: 2537663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of microgravity on brain neurotransmitter receptors.
    Miller JD; McMillen BA; McConnaughey MM; Williams HL; Fuller CA
    Eur J Pharmacol; 1989 Feb; 161(2-3):165-71. PubMed ID: 2542043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and molecular characterization of neurotransmitter receptors.
    Venter JC; Eddy B; Schaber JS; Lilly L; Fraser CM
    Prog Clin Biol Res; 1983; 135():183-206. PubMed ID: 6320219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.